mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
-0.11 |
0.6 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
-0.12 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.12 |
0.6 |